New Report Highlights Recent Proposals to Control Prescription Drug Costs

Lindsey CopelandMedicare WatchLeave a Comment

A new report from the Kaiser Family Foundation examines a number of these proposed and recent changes—including those related to the Part D benefit design, the Low Income Subsidy (LIS) program, drug importation, generic drug availability, and price transparency—outlining the implications for people with Medicare and the program itself. This comprehensive resource will be updated ongoingly to reflect evolving policy discussions. Read More...

Lawsuit Seeks to Improve Medicare Beneficiary Access to Nursing Facilities

Julie CarterMedicare WatchLeave a Comment

Currently, people with Medicare cannot appeal the decision to classify them outpatients, but a court case—Alexander v. Azar—may change that. In 2011, seven plaintiffs filed a class action lawsuit to try to gain the right to appeal the decision to classify them as outpatients in observation stay instead of as inpatients who would potentially be eligible for SNF coverage. After many twists and turns, the case has finally made it to trial this week in a Connecticut court. If successful, the lawsuit would ensure that beneficiaries can appeal decisions made by hospitals that reduce their eligibility for Medicare coverage of SNF care. Read More...

CMS Proposes Hospital Transparency Rules

Casey SchwarzMedicare WatchLeave a Comment

The Centers for Medicare & Medicaid Services recently announced a proposal designed to increase hospital price transparency. Under the draft rule, hospitals would be required to publicly disclose the price they negotiate with each insurer for almost every service, drug, and supply they provide to patients. If that sounds like a lot to sift through to figure out which facility Read More...